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ABSTRACT
Objectives: To present a relatively novel method for modeling length-of-
stay data and assess the role of covariates, some of which are related to
adverse events. To undertake critical comparisons with alternative models
based on the gamma and log-normal distributions. To demonstrate the
effect of poorly ﬁtting models on decision-making.
Methods: The model has the process of hospital stay organized into
Markov phases/states that describe stay in hospital before discharge to
an absorbing state. Admission is via state 1 and discharge from this ﬁrst
state would correspond to a short stay, with transitions to later states
corresponding to longer stays. The resulting phase-type probability
distributions provide a ﬂexible modeling framework for length-of-stay
data which are known to be awkward and difﬁcult to ﬁt to other
distributions.
Results: The dataset consisted of 1901 patients’ lengths of stay and values
for a number of covariates. The ﬁtted model comprised six Markov
phases, and provided a good ﬁt to the data. Alternative gamma and
log-normal models did not ﬁt as well, gave different coefﬁcient estimates,
and statistical signiﬁcance of covariate effects differed between the models.
Conclusions: Models that ﬁt should generally be preferred over those that
do not, as they will produce more statistically reliable coefﬁcient estimates.
Poor coefﬁcient estimates may mislead decision-makers by either under-
stating or overstating the cost of some event or the cost savings from
preventing that event. There is no obvious way of identifying a priori when
coefﬁcient estimates from poorly ﬁtting models might be misleading.
Keywords: covariate dependence, length of stay, Markov chain, right
skewed data, statistical modeling.
Introduction
Researchers and decision-makers should understand factors
associated with increasing or decreasing lengths of stay among
hospital patients [1]. Understanding how age, sex, comorbid
conditions, and iatrogenic events (such as health care-acquired
infection [HAI]) inﬂuence length of stay (LoS) will aid program
evaluation and the difﬁcult task of managing hospital systems.
LoS is an appropriate unit of currency for decision-making
because most ﬁnancial expenditures made by hospitals are ﬁxed
in the short run [2,3]. A decision that reduces lengths of stay will
not release much cash. Bed days will fall vacant and these can be
redeployed for some change to variable costs. The economic cost
of the marginal bed is the decision-maker’s valuation of the
alternate use of that bed day (i.e., the opportunity cost). If there
is no effective demand for hospital services then the marginal bed
day is worth 0. Long waiting lists observed in many countries,
however, suggest otherwise. Another interesting issue is that
events associated with increasing LoS take place as the hospital
admission progresses and the chances of those events change
with the duration of the admission. HAI is a good example [4].
This requires a ﬂexible approach to modeling LoS data that allow
the timing of events to be captured. The fact that LoS data are
right skewed with a mode near 0 and heavy tails is also very
important. Statistical methods are vulnerable to heteroscedastic
variation and biased estimates of coefﬁcients of predictors [5].
The best way to model LoS and other right skewed data has
been debated in the literature. Logarithmic (or other) transfor-
mations of the outcome variable are often used with ordinary
least squares (OLS) regression. The weakness of this is that
log-LoS is not useful for policy making, log-models are about
geometric, not arithmetic, means, and retransformation is com-
plicated by heteroscedasticity [6,7]. A generalized linear model
(GLM) using the gamma error distribution and a log-link func-
tion avoids the problem of retransformation and is recommended
by others. For example, Dodd et al. [1] compared ﬁve different
approaches to modeling cost data; these were OLS regression on
untransformed and log-transformed outcomes, OLS with boot-
strapping and robust standard errors, median regression and
gamma regression using a log-link function. The best residuals
were obtained from a gamma regression but no method could
predict extreme costs, and for this they blamed an incomplete set
of covariates. Manning and Mullahy [8] assessed the perfor-
mance of OLS regression with a log-transformation and gamma
regression with a log-link function on nonzero and right skewed
data. They identiﬁed problems with both methods with the ﬁrst
“biased in the face of heteroscedasticity if not appropriately
retransformed” and the second yielding “very imprecise esti-
mates if the log-scale error is heavy-tailed.” They found the
gamma method to be robust to most data generating mechanisms
that were not heavy tailed or had high error variance on the
log-scale. The authors suggest a modiﬁed Park’s test [9] in order
to aid model selection. This procedure determines the relation-
ship between the raw-scale mean and raw-scale variance for
competing OLS and GLM models. Basu et al. [10] compared the
performance of four different estimators under a range of data
generating mechanisms. In particular they considered OLS on
log-transformed outcomes, gamma regression with a log-link,
Weibull regression with a log-link, and Cox proportional hazards
regression. The gamma with log-link model provided the only
estimates that performed reasonably well for all simulations.
The purpose of this article is to describe a relatively novel
approach to modeling LoS data. Patients’ stay in hospital is
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modeled by a Markov process in continuous time with a number
of different states, such that patients either progress to another
state corresponding to increasing their LoS, or they are dis-
charged to an absorbing state corresponding to discharge from
hospital. This leads to a very general class of probability distri-
butions describing the random time that elapses before the
process gets to the absorbing state. These distributions thus
provide considerable ﬂexibility in modeling positive random
variables such as times to some event such as discharge from
hospital [11]. The underlying (or hidden) Markov process can
also reveal features that might differentially inﬂuence short and
long stays in hospital [12,13]. Recently [14] such a model has
been used with differential costs associated with occupancy of the
states of the Markov process (typically, time spent in earlier states
might be more costly than time spent in later states) to describe
total costs while in the system. In this article, costs associated
with the effects of covariates such as HAI in predicting patients’
progress through the modeled states are assessed using marginal
estimates of excess LoS attributable to both continuous and
binary covariates. Comparisons are made with estimates from
using standard alternative distributions such as the gamma and
log-normal.
Methods
Data
Our data were collected between October 2002 and January
2003 from patients admitted to a 712 bed tertiary referral hos-
pital and a 312 bed district hospital in South-East Queensland,
Australia. Inclusion criteria were 18 years of age and a
minimum inpatient stay of one night. Consecutive patients were
identiﬁed from a register of new admissions. Data were collected
by ﬁve research nurses who were seconded from the wards of
the tertiary hospital. Patients were recruited and demographic
data collected using “Personal Digital Assistants” that linked
to a custom designed Microsoft Access database (Microsoft,
Redmond, WA). After recruitment, data collection was com-
pleted from a review of the patients’ medical records, Hospital
Based Corporate Information Systems (HBCIS, Queensland
Health, Brisbane, QLD, Australia) and the hospital pathology
system, Auslab (PJA Computer Consultants and PJA Solutions,
Melbourne, VIC, Australia). See Graves et al. [15,16] for more
details of data collection and deﬁnitions. We collected additional
data from the Australian Institute of Health & Welfare that
describe the mean LoS for all the International Classiﬁcation of
Disease (ICD-10) patient diagnosis codes in our primary data set.
One criterion was that only those patients with a single code
assigned to their stay were included, thus we obtained the mean
LoS for what we assumed to be an uncomplicated admission.
Statistical Model
A Markov chain in continuous time on states 1, 2 . . . n, and
n + 1 represented schematically in Figure 1, is used to describe
patients’ LoS in hospital. Here the parameters l1, l2 . . . ln-1
describe sequential transitions between the transient states (or
phases) 1, 2 . . . n and m1, m2 . . . mn (with at least mn > 0) transi-
tions from these states to an absorbing state n + 1, which repre-
sents discharge from hospital. Admission to hospital is via state
1 and discharge from this ﬁrst state would correspond to a short
stay in hospital and straightforward treatment, with transitions
to later states and subsequent discharge corresponding to longer
stays in hospital because of more involved treatment and/or
complications. Such probability distributions are known as
phase-type (Neuts [17], Chapter 1); they generalize the exponen-
tial (n = 1) distribution and the gamma or Erlang (l1 = l2 = . . .
= ln-1 = mn and m1 = m2 = . . . mn-1 = 0) distributions. They have
coefﬁcient of variation ≥ 1 n , and can show long right tails with
a mode near 0 which are typical of LoS data.
Taking a holistic view of a model with discrete phases (1,
2 . . . n), parameters describing the later phases (mn-1, ln-1, and mn)
will have greater inﬂuence on the upper tail of the distribution,
while those from the early phases (m1, l1, and m2, l2) will tend to
affect the lower part of the distribution. From observed LoS data,
the li and mi parameters can be estimated by maximum likelihood
and the underlying (or hidden)Markov chain can be interpreted in
terms of different, sequential phases of the patients’ treatment
before discharge from hospital, as described by Faddy and
McClean in [12,13]. The mean sojourn time in phase i (= 1,
2 . . . n) is 1 μ λi i+( ) and the probability of a subsequent transition to
phase i + 1 is λ μ λi i i+( ) (or probability
μ
μ λ
i
i i+( ) of absorption into
state n + 1), where ln is here taken to be 0 as phase n is the last in
the sequence. So that the mean time to absorption can be written:
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With the mean LoS dependent on covariates x = (x1,
x2 . . . xk) via a log-link as exp (a + xbT), the additional param-
eters of covariate coefﬁcients b = (b1, b2 . . . bk) can also be
estimated by maximum likelihood. This can be achieved by
numerically maximizing the log-likelihood, using optimization
routines such as the Nelder-Mead simplex algorithm in MATLAB
(MathWorks, Natick, MA). For models of this form the variance-
mean relationship will be quadratic:
variance mean∝ 2
but they are not GLMs.
Choosing the Number of Phases
Increasing n from a single phase (exponential distribution) ﬁt will
always increase the maximized log-likelihood, but after a certain
value of n, subsequent increases will have little effect and criteria
such as Akaike Information Criterion (AIC) or Bayesian Infor-
mation Criterion (BIC), see chapter 4 of Davison [18], can be
used as a guide. Some assessment of the goodness of ﬁt of the
estimated distribution to the data provides further information
about the ﬁtted model. In particular, extra phases may be neces-
sary to accommodate a long upper tail of the distribution of the
observed data. Alternatively, a more parsimoniously parameter-
ized structure may emerge as the number of phases increases, as
in Faddy [11], which can then be exploited in determining an
optimal value of n.
1 2 n
n+1
2λ 1−nλ
2μ nμ1μ
1λ
Figure 1 Schematic representation of the general Markov chain model.
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Alternative Models
Both the gamma and log-normal distributions, like the phase-
type model, have quadratic variance-mean relationships,
although only the gamma model is a GLM, see chapter 10 of
Davison [18].
Covariates
The excess length of a patient’s stay in hospital was assessed
relative to an estimate of the normal LoS from an uncomplicated
admission. This quantity is denoted by x0 in Table 1, and
including log (x0) as an offset covariate in the model (i.e., with
coefﬁcient 1) will result in the mean LoS being modeled multipli-
catively relative to x0 according to E(LoS) = x0 exp (a + xbT) The
other covariates x = (x1 x2 . . . x10) were chosen as the expectation
was that they will affect the mean LoS but this set is certainly not
exhaustive; the aim is to demonstrate the method here.
Assessment of Model Fits
This was done using log-likelihood values, residual quantile–
quantile plots, BIC values deﬁned as 2 ¥ log-likelihood - number
of estimated parameters ¥ log (number of data-points used in the
estimation), generalized Pearson statistics deﬁned as sums of
squared standardized residuals where these are (observation -
ﬁtted mean)/standard deviation, and coverage properties of 95%
prediction intervals.
Results
The dataset consisted of 1901 patients’ lengths of hospital
stay and values for all covariates. Some descriptive statistics for
these data are provided in Table 1. Maximum likelihood ﬁtting
of the phase-type models to the data without any covariate
dependence (but with x0 offset) for n = 1, 2, 3, etc. resulted
in estimated models for n  4 with ˆ ˆ ˆλ λ λ1 2 3= = = − n .
ˆ ˆ ˆμ μ μ1 2 3 0= = = =− n and ˆ ˆ ˆμ λ λn n n− − −+ =2 2 3, shown schemati-
cally in Figure 2. Such a phase-type structure corresponds to a
gamma component from the ﬁrst n - 2 phases providing a mode
near 0, with phases n = 1 and n lengthening the tail of the
distribution to increase the skewness. Fitting such a model to the
data with covariate dependence resulted in an overall maximum
log-likelihood of -4903.52 occurring for n = 6. A quantile–
quantile plot for the residuals, deﬁned here as observed LoS
divided by the estimated mean from the ﬁtted model, is shown in
Figure 3 with the solid line showing the mean and the dashed
lines point-wise 95% probability intervals. The model is clearly a
very good ﬁt to the data.
Alternative models with the same form for the mean LoS and
using gamma and log-normal distributions rather than the above
phase-type distribution ﬁtted the data less well with lower log-
likelihoods of -5106.55 for the gamma model and -4922.81 for
the log-normal, but these models do involve fewer parameters.
Allowing for this by maximizing BIC values still results in
the above phase-type model being preferred over the gamma
and log-normal alternatives: BIC = -9927.85, -10303.71, and
-9936.21, respectively, for these three models. The correspond-
ing quantile–quantile plots are shown in Figures 4 and 5. These
plots illustrate that the ﬁt of the gamma model is very poor, and
although the log-normal model ﬁt is much better it is still inferior
to the phase-type model ﬁt with 418 (out of 1901) observed
quantiles above the upper limits of the 95% probability intervals
and 491 below the lower limits (cf. 1 and 26, respectively, for the
phase-type model ﬁt).
Generalized Pearson statistics also favor the phase-type
model with values 2065.2 on 1885 df for phase-type, 3985.0 on
1889 df for gamma, and 3077.4 on 1889 df for log-normal.
The three ﬁtted (residual) distributions have 2.5 and 97.5
percentiles equal to 0.15 and 4.20 (phase-type), 0.071 and 3.12
(gamma), and 0.14 and 3.60 (log-normal), leading to 95% pre-
diction intervals for LoS formed by multiplying the estimated
means by these percentiles. Comparing the resulting prediction
intervals with the actual observed LoS values in the dataset shows
that the nominal coverage probability of 0.95 is about right for all
Table 1 Variables used in the modeling
Dependent variable = Length
of stay in Hospital (LoS)
Range 0.44–170.9,
mean 7.25 days
x0 =mean LoS for ICD-10 code* Range 1–72, mean 3.22 days
x1 = log (age) Range 2.90–4.61, mean 4.02
(log) years
x2 = sex (female/male) Binary 0/1, 55% male
x3 = discharge destination (death/survive) Binary 0/1, 97% survive
x4 = admission type (emergency/
nonemergency)
Binary 0/1, 59% nonemergency
x5 = anti-coagulant therapy during
admission
Binary 0/1, 15% occurrence
x6 = pressure ulcer during admission Binary 0/1, 4.7% occurrence
x7 = fecal incontinence during admission Binary 0/1, 7.3% occurrence
x8 = gastrointestinal bleeding during
admission
Binary 0/1, 5.4% occurrence
x9 = health care-acquired infection Binary 0/1, 6.1% occurrence
x10 = surgical procedure Binary 0/1, 37% occurrence
*This variable describes the estimated LoS for an uncomplicated admission.
1−nλ
1nμ −
2nλ −
n−1
nμ
1λ
1
2nμ −
n+1
n−2 n
4nλ − 3nλ −
n−3
Figure 2 Schematic representation of the ﬁtted Markov chain model.
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Figure 3 Residual quantile–quantile plot for the phase-type model, mean (—)
and point-wise 95% probability intervals (- - -).
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three models with around 100 (out of 1901) observations falling
outside the prediction intervals, but these are split 57 below the
lower limit and 50 above the upper limit for the phase-typemodel,
9 and 82 for gamma, and 42 and 66 for log-normal. The phase-
type model thus has the more symmetric split here corresponding
to the actual construction of the prediction intervals.
Some similarities between the covariate coefﬁcient estimates
shown in Table 2 are apparent with covariates x1, x4, x5, x7, x8,
x9, and x10 being signiﬁcant (P-values < 0.05), and x2 and x6
non-signiﬁcant (P-values > 0.05) predictors of LoS from all three
models. However, x3 is a signiﬁcant (P-value < 0.05) predictor in
the phase-type and log-normal models, but not in the gamma
model.
Mean LoS values were estimated from these models as aver-
ages over the patient mix in the dataset. The differences in mean
LoS for each binary covariate, when they were set equal to 0 and
then 1, are presented in Table 3. Also shown in Table 3 are
estimated mean LoS differences from the age covariate dichoto-
mized >60/60 years. Relative to the better ﬁtting phase-type
model, the gamma and log-normal models give different esti-
mates of change in mean LoS associated with different covariate
values, with the gamma model showing some quite substantial
differences, although the log-normal and phase-type results are
more similar despite the log-normal model being an inferior ﬁt.
Conclusions
A novel method has been used for modeling LoS data and is
relevant to other data that are right skewed. The preference for
modeling the outcome “LoS” instead of some monetary valua-
tion of hospital cost stems from a belief that many decisions
about health-care investments are made in the short run where
most ﬁnancial expenditures are made for costs which are ﬁxed.
Roberts et al. [3] found 84% of hospital costs in the United
States to be ﬁxed in the short run and Plowman et al. [2] found
that >90% of the expenditures made for a UK District General
Hospital were for ﬁxed costs. In this case the change in costs
from some intervention that reduces LoS is the value of the
alternative use of bed days and the expenditures made for ﬁxed
costs are irrelevant. In most health-care systems demand for
hospital services outstrips the supply suggesting a positive eco-
nomic value for bed days.
The statistical method reported here is novel with the process
of hospital stay organized into Markov phases, or compartments,
that describe stay in hospital in terms of occupancy of transient
states before discharge to an absorbing state. The resulting phase-
type probability distributions provide a ﬂexible modeling frame-
work for LoS data which are known to be awkward and difﬁcult
to ﬁt to other distributions. The quantile–quantile plots in
Figures 3–5 illustrate that phase-type modeling provides a better
ﬁt than alternatives such as gamma and log-normal based models.
The results in Table 3 illustrate the differences between estimates
from using these different models, and demonstrate the need for
critical model selection. The reason for the better ﬁt of models
using phase-type distributions is that these distributions are better
able to accommodate extreme values, because of the hidden
Markov process differentially characterizing short and long stays
in hospital. For example, healthier patients would be more likely
to be discharged from earlier phases of the Markov process, and
patients with additional health problems more likely to progress
into subsequent phases until, eventually, they are all discharged.
The longest stay in our set of data was a patient who spent 171
days in hospital. Although not exploited here, theMarkov process
does model the dynamic nature of a stay in hospital. Events that
occur during an admission that affect the duration of the admis-
sion but are also inﬂuenced by the duration of the admission could
be described using this modeling. Data would have to be observed
longitudinally and the advantage is that the order of events can be
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Figure 4 Residual quantile–quantile plot for the gamma model, mean (—) and
point-wise 95% probability intervals (- - -).
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Figure 5 Residual quantile–quantile plot for the log-normal model, mean (—)
and point-wise 95% probability intervals (- - -).
Table 2 Estimated regression coefﬁcients (with standard errors in
brackets)
Phase-type Gamma Log-normal
Constant -0.94 (0.25) -1.60 (0.25) -1.14 (0.26)
x1 0.27 (0.051) 0.46 (0.051) 0.31 (0.053)
x2 -0.064 (0.037) -0.056 (0.038) -0.059 (0.039)
x3 0.30 (0.12) 0.20 (0.12) 0.30 (0.12)
x4 0.15 (0.042) 0.16 (0.042) 0.15 (0.043)
x5 0.32 (0.053) 0.15 (0.054) 0.28 (0.055)
x6 0.16 (0.10) 0.16 (0.096) 0.15 (0.10)
x7 0.62 (0.084) 0.79 (0.082) 0.65 (0.084)
x8 0.38 (0.084) 0.41 (0.085) 0.41 (0.086)
x9 0.98 (0.085) 1.03 (0.083) 1.02 (0.085)
x10 0.35 (0.042) 0.30 (0.043) 0.34 (0.044)
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modeled. A good example is that infection increases duration of
hospital stay but risk of infection increases with duration of stay.
This problem of endogenous variables [4] can potentially be
avoided using Markov process modeling.
The relevance of this work is demonstrated by consideration
of how the results of a poorly ﬁtting model, such as the model
based on the gamma distribution, might impact on policy
making. Consider this simple example. Rates of HAI are
approximately 7% in the UK [2]. A medium size health-care
system, such as the National Health Service of the UK, will deal
with 5.75 million inpatient admissions per year [19] and so we
can expect approximately 400,000 cases of HAI per year. Com-
pared with the phase-type model, the gamma model will over-
state the cost of HAI by some 600,000 hospital bed-days. This
exaggerates the size of the problem and so may inﬂuence
decision-making. If an explicit decision-analytic model were
developed for some technology that reduces rates of HAI by say
1%, the cost savings associated with that technology would be
exaggerated. With the incremental bed days valued at £500 each
by decision-makers, the results from the gamma model would
exaggerate annual cost savings by around £3 million and this
could affect the decision to adopt such an infection control
program. The gamma model is currently preferred by health
economists, see Dodd et al. [1], Manning and Mullahy [8], and
Basu et al. [10]. If results from the log-normal model were used
this would lead to less extreme estimates but would still exag-
gerate the gross cost of HAI by some 152,000 days and overstate
the cost savings from a 1% reduction in rates by around
£760,000. The estimated effect of age is also vulnerable to the
modeling used. The gamma model overstates quite considerably
the effect of age on LoS for the elderly relative to the young
(Table 3), with the log-normal showing a similar tendency but of
smaller magnitude. This will introduce problems for decision-
analytic modelers who might use these estimates to predict how
long individuals will spend in hospital based on their age. Similar
arguments can be made regarding the other covariates.
The problems described arising from the poorly ﬁtting gamma
and (to a lesser extent) log-normal models are deﬁned by Briggs
et al. as model or structural uncertainty [20], which is exogenous
to the process of decision-making. In contrast to parameter uncer-
tainty, which can be propagated through a decision model via
probabilistic sensitivity analysis, this type of uncertainty relates to
the modeling framework itself. Briggs et al. [20, p. 83] point out
that “any estimate of uncertainty based on propagating param-
eter uncertainty through the model will be conditional on the
structural assumptions of the model and it is important to recog-
nise that different assumptions could impact the estimated uncer-
tainty.” Bayesian Model Averaging (BMA) attempts to account
for model uncertainty when considering parameter estimation.
An approximate analysis uses BIC as posterior probabilities on
the scale of 2 ¥ log-probability. So here, using the earlier BIC
values, the phase-type model is about 65 times more probable
than the log-normal alternative and the gamma model has negli-
gible probability. BMA thus gives posterior probabilities of
65
66 for the phase-type model, 0 for the gamma and 166 for the
log-normal, and essentially the phase-type estimates when aver-
aging over these three different models.
Although the phase-type model is likely to produce a better ﬁt
for heavily skewed data, it does involve a non-trivial modeling
process which has two objectives: ﬁrst, modeling the shape of
the underlying distribution by the compartmental model; and
second, ﬁtting a regression model to ﬁnd systematic effects. One
difﬁculty is that, to some extent, these two aspects can be con-
founded so that particular sets of observations could be modeled
by either a new compartment say, or a new covariate. The
modeling is iterative and model complexity for both aspects has
to be balanced by worthwhile improvements in model ﬁt. This
can be carried out by sequentially ﬁtting a series of models by,
what are called in stepwise regression, forward and backward
steps, for both the compartmental and regression parts of the
model with several steps needed before satisfactory models are
found. This can be done using routines available in MATLAB
with a pragmatic choice being made as regards the actual form of
the selected model. Current research by the authors is using
Bayesian computational methods of variable dimension search in
order to automate the process of model selection for both of the
above aspects of the modeling process.
In conclusion, the method proposed here ﬁts the data better
than existing alternatives that are recommended in the health
economics literature. Models that ﬁt should generally be pre-
ferred over those that do not, as they will produce more statis-
tically reliable coefﬁcient estimates. Poor coefﬁcient estimates
will mislead decision-makers by either understating or overstat-
ing the cost of some event or the cost savings from preventing
that event. The gamma appears to be particularly bad for the
data used here, and will mislead the decision-maker the most.
The log-normal is better than the gamma but does not ﬁt as well
as the phase-type. The consequences of using a log-normal are
less serious as the coefﬁcient estimates are relatively closer to the
phase-type. However, the dynamic nature of hospital stays
cannot be captured without using phase-type modeling and a
Markov process in continuous time with a number of different
states. The next research steps should be to test this novel method
with different datasets, include time dependent covariates to take
advantage of the method, and develop easier ways to implement
these statistical procedures.
Supporting Information
Supporting information for this article can be found at [1S]: http://
www.ispor.org/publications/value/ViHsupplementary.asp
Table 3 Estimated differences in mean of length of stay (days) associated with different covariate values (with standard errors in brackets)
Phase-type Gamma Log-normal
Age (>60/60 years) 5.29 (0.41) 7.13 (0.49) 5.52 (0.42)
Sex (male/female) -0.60 (0.35) -0.56 (0.38) -0.54 (0.35)
Discharge destination (survive/death) 2.48 (0.86) 1.83 (0.97) 2.42 (0.82)
Admission type (non-emergency/emergency) 1.37 (0.37) 1.57 (0.39) 1.32 (0.38)
Anticoagulant therapy during admission 3.36 (0.62) 1.58 (0.59) 2.81 (0.61)
Pressure ulcer during admission 1.54 (1.03) 1.67 (1.06) 1.43 (1.01)
Fecal incontinence during admission 6.97 (1.19) 9.83 (1.37) 7.22 (1.19)
Gastrointestinal bleeding during admission 4.18 (1.09) 4.77 (1.19) 4.38 (1.11)
Health care-acquired infection 12.48 (1.63) 13.98 (1.70) 12.86 (1.62)
Surgical procedure 3.35 (0.45) 3.08 (0.47) 3.16 (0.45)
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